LIMG
LIMITATION OF GOODS RECEIVED FROM IB
28/05/2026
Voltar para busca
Dado oficial do USPTO
BOND PRIME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BOND PRIME
ST13
US500000079378815Classe
5, 9, 10, 42
Pedido
79378815
Registro
8268333
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
29/05/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 10, 42
Data de depósito
17/08/2023
Data de registro
26/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/05/2026
Última transação
29/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
82
Localização do titular
AU
Examinador
LAWRENCE, SUSAN KASTRINER
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Leica Biosystems Melbourne Pty Ltd
Representantes
ALEXIS P. GRILLI NIXON PEABODY LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
pharmaceutical and veterinary preparations namely reagents for medical and diagnostic purposes reagents for veterinary purposes; diagnostic preparation for medical use; antibody reagents used for the detection of antigens in cells and tissue for medical purposes; chemical reagents and diagnostic preparations for medical and veterinary purposes; medical diagnostic reagents; clinical medical reagents; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridisation detection; diagnostic preparations in the nature of in situ-hybridisation probes for medical and veterinary purposes; diagnostic preparations in the nature of epitope retrieval solutions; enzymes and enzyme preparations for medical and diagnostic purposes; diagnostic preparations in the nature of diagnostic histological dye and stain solutions for medical purposes; dewaxing and wash buffers used with the aforementioned preparations for use in disease testing; diagnostic preparations for clinical or medical laboratory use
Classe 9
diagnostic apparatus and instrumentsnot for medical purposesfor staining and visualisation of tissue or cell based samples for research and scientific use; laboratory apparatus for detection of tissue and/or cell based samples not for medical purposes; recorded and downloadable software for identifying and diagnosing cancer and other diseases and processing digital images; analysis apparatus for laboratory use for analyzing the results of tissues and cell based samples obtained through operation of tissue and cell sample staining apparatus not for medical purposes; diagnostic measuring apparatus used to identify and/or diagnose cancer and other diseasesnot for medical use; diagnostic laboratory testing apparatus incorporating chemical reagents for analysing the results of tissues and cell based samplesnot for medical use
Classe 10
Diagnostic apparatus and instruments for medical use for staining and/or visualization of tissue or cell based samples for diagnostic or medical use for pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; diagnostic apparatus for detection of tissue and/or cell based samplesall for medical purposes for pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; medical analysis and medical measuring apparatusnamely medical diagnostic instruments for the analysis of body fluids and tissue for medical diagnostic uses; medical apparatus and instruments for pathology purposesfor pathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; apparatus for use in medical analysismedical diagnostic apparatus for pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; testing apparatus for medical purposeshistopathology instrumentshaematology instrumentsboth for clinical purposesfor pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological staining; diagnostic medical apparatus namelyhistopathology instrumentshaematology instrumentsboth for clinical purposesfor pathology purposespathological assessmentpathological testingperforming immunohistochemistry and in situ-hybridisation staining reactionshistological and pathological stainingfor promoting and controlling reaction on microarrays or under slide covertiles; in-vitro diagnostic testing apparatus incorporating chemical reagents for medical use; medical specimen collection slides for specimen collection in surgery
Classe 42
Medical research; installation and integration of softwareincluding within existing hospital and laboratory infrastructure; maintenanceservicingupdating and upgrading of software; all the aforementioned for use in connection with medical analysisdiagnosis and research
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/05/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
26/05/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/04/2026
PUBO
PUBLISHED FOR OPPOSITION
07/04/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/04/2026
EXPT
EXPARTE APPEAL TERMINATED
16/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/03/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
16/03/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/03/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
16/03/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/03/2026
EXPI
EX PARTE APPEAL-INSTITUTED
04/03/2026
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
04/03/2026
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
04/03/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/03/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/03/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/03/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/09/2025
GNFR
FINAL REFUSAL E-MAILED
05/09/2025
CNFR
FINAL REFUSAL WRITTEN
05/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2025
RFNT
REFUSAL PROCESSED BY IB
22/03/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/03/2025
RFRR
REFUSAL PROCESSED BY MPU
04/03/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/03/2025
CNRT
NON-FINAL ACTION WRITTEN
28/02/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
26/02/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/02/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/02/2025
CNRT
NON-FINAL ACTION WRITTEN
29/04/2024
DOCK
ASSIGNED TO EXAMINER
17/04/2024
MAFR
APPLICATION FILING RECEIPT MAILED
19/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/09/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/09/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BOND PRIME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.